“…Tumor recognition is independent of classical MHC molecules, there is no defined requirement for antigen processing [13], and various tumor ligands have been implicated including HSP60 [28] and an F1 ATPase-related structure [37]. Cell lines expanded after stimulation with phosphoantigens or tumors are enriched for the Vγ2-Jγ1.2 rearrangement [18] and are potently cytotoxic for some tumors [10,38]. Stimulation also induces expression of Type 1 cytokines (IFN-γ, TNF-α, RANTES, MIP-1α, MIP-1β and Lymphotactin among others) [8,14,29,40] and can lead to surface expression of CD107a, a marker for cytotoxic effector cells [14].…”